title: Dual vs triple immunosuppressive therapy: equally safe and effective in kidney transplantation?
authors.affiliation: National Hospital, Oslo, Norway.
authors.forename: D
authors.initials: D
authors.lastname: Albrechtsen
authors.forename: A
authors.initials: A
authors.lastname: Flatmark
authors.forename: H
authors.initials: H
authors.lastname: Brynger
authors.forename: L
authors.initials: L
authors.lastname: Frødin
authors.forename: C G
authors.initials: CG
authors.lastname: Groth
authors.forename: N
authors.initials: N
authors.lastname: Persson
mesh_terms: D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use*; D003524:Cyclosporins / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006085:Graft Survival; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D016030:Kidney Transplantation / Q000276:immunology*; D008875:Middle Aged; D011239:Prednisolone / Q000627:therapeutic use*
chemical_list: D003524:Cyclosporins; D011239:Prednisolone; D001379:Azathioprine